We are international
Donate
• health professionals TEXT SIZE   
   back

KOS 2007: Prognostic Factors for Multiple Myeloma in the Era of Novel Therapies
Joan Bladé
Hematology Department
Institut of Hematology and Oncology
IDIBAPS, HospitalClínic
Barcelona, Spain
06.27.07

Be the first to comment

 related articles